Prevalence of prothrombotic abnormalities in patients with acute mesenteric ischemia

World Journal of Surgery

Volumn 29, Issue 9, 2005, Pages 1135-1138

  Aǧaoǧlu, Nazim ^a,c   Türkyilmaz, Serdar ^a   Ovali, Ercüment ^a   Uçar, Fahri ^a   Aǧaoǧlu, Celal ^b  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b Golbasi Vocational School   (Turkey)

^c Nazim Aǧaoǧlu ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; MUTANT PROTEIN; PROTEIN C; PROTEIN S; PROTHROMBIN; PROTHROMBIN G20210A; UNCLASSIFIED DRUG;

ACUTE MESENTERIC ISCHEMIA; ADULT; AGED; ANTITHROMBIN III DEFICIENCY; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ETHNOLOGY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HOMOZYGOSITY; HUMAN; ISCHEMIA; MALE; MUTATIONAL ANALYSIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN C DEFICIENCY; PROTEIN DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOSIS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTITHROMBIN III; BLOOD COAGULATION DISORDERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR V; FEMALE; HUMANS; ISCHEMIA; MALE; MESENTERIC VEINS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOSIS;

EID: 27744551943     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-7692-5     Document Type: Article

References (24)

1. Markis M, Rosendaal FR, Preston FE. Familial thrombophilia: genetic risk and management. J. Intern. Med. Suppl. 1997;740:9-15
2. Margaglione M, D'Andrea G, d'Addedda M, et al. The methylene- tetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb. Haemost 1998;79:907-911
3. AǧaoǧLu N, Türkyilmaz S, Arslan MK. Prothrombotic disorders in patients with mesenteric vein thrombosis. J. Invest. Surg. 2003;16:299-304
4. Gurgey A, Haznedaroǧlu IC, Agesel T, et al. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkisk patients with thrombosis. Am. J. Hematol. 2001;67:107-111
5. Akar N, Akar E, Dalgin G, et al. Frequency of factor V 1691 G-A mutation in Turkish population. Thromb. Haemost. 1997;78:1527-1529
6. Akar N, Misirlioǧlu M, Akar E, et al. Prothrombin gene 20210 G: a mutation in Turkish population. Am. J. Hematol 1998;58:249
7. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure of extracting DNA from human nucleated cells. Nucleic Acids Res 1998;16:1215
8. Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin. Hematol. 1997;34:171-187
9. Shen MC, Lin JS, Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb.Res. 1997;87:377-385
10. Lin JS, Shen NC, Tsay W. The mutation at position 20210 in the 3′-untranslated region of the prothrombin gone is extremely rare in Taiwanese Chinese patients with venous thrombophilia. Thromb. Haemost. 1998;80:343
11. Rees DC, Cox M, Clegg JB. World distribution of FV Leiden. Lancet 1995;346:1133-1134
12. Ridker PM, Miletich JP, Hennekens CH, et al. Ethnic distribution of FV Leiden in 4047 men and women. J.A.M.A. 1997;277:1305-1130
13. Cattaneo M, Chantatangkul V, Taioli E. The G20210: a mutation of the prothrombin gene in patients with previous first episodes of deep vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase TT677 and plasma prothrombin levels. Thromb. Res. 1999;93:1-8
14. Gómez RR, Cuesta M, García M. Prevalence of the FV Leiden mutation in the Spanish population [abstract]. Thromb. Haemost 1997;77:224
15. Rosendaal FR, Doggen CJ, Zivelin A. Geographic distribution of the 20210 G to A prothrombin variant. Thromb. Haemost. 1998;79:706-708
16. Souto JC, Coll I, Llobe D, et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb. Haemost 1998;80:306-309
17. Genoud V, Castrion M, Annichino-Bizzacchi J, et al. Prevalence of three prothrombotic polymorphisms factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase (MTHFR) C 677T in Argentina. Thromb. Res 2000;100:127-131
18. Ma J, Stampfer MJ, Hennekens CH, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in U.S. physicians. Circulation 1996;94:2410-2416
19. Jacques PF, Bostom AG, William RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;3:7-9
20. Maurizio M, Giovanna DA, Marina DA, et al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the factor V Leiden and the prothrombin A20210 mutation. Thromb. Haemost 1998;79:907-911
21. Rintelen C, Pabinger I, Leckner K, et al. No evidence for an increase of the risk of venous thrombosis in patients with factor V Leiden by the homozygous mutation in the methylenetetrahydrofolate gene. Blood Coagul Fibrinolysis 1999;10: 101-105
22. Morita H, Taguchi J, Kurihara H, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997;95:2032-2036
23. Motti C, Gnasso A, Bernardini S. Common mutation of methylenetetrahydrofolate reductase; correlation with homocysteine and other risk factors for vascular disease. Atherosclerosis 1998;139:377-383
24. Camacho Vanegas O, Giusti B, Restropo Fernandez CM, et al. Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians. Thromb. Haemost. 1998;79:883-884